UK markets open in 3 hours 6 minutes
  • NIKKEI 225

    29,118.68
    +169.95 (+0.59%)
     
  • HANG SENG

    28,842.13
    +103.23 (+0.36%)
     
  • CRUDE OIL

    71.20
    +0.29 (+0.41%)
     
  • GOLD FUTURES

    1,866.40
    -13.20 (-0.70%)
     
  • DOW

    34,479.60
    +13.40 (+0.04%)
     
  • BTC-GBP

    27,545.74
    +2,648.10 (+10.64%)
     
  • CMC Crypto 200

    970.24
    +28.43 (+3.02%)
     
  • ^IXIC

    14,069.42
    +49.12 (+0.35%)
     
  • ^FTAS

    4,068.33
    +24.32 (+0.60%)
     

Eagle Pharmaceuticals to Present at the 2021 RBC Capital Markets Global Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
  • Oops!
    Something went wrong.
    Please try again later.

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ("Eagle" or the "Company") today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the 2021 RBC Capital Markets Global Healthcare Conference as follows:

Date:

Tuesday, May 18, 2021

Time:

1:20 p.m. Eastern Time

Webcast:

https://event.on24.com/wcc/r/3173733/CEA9B803E5C77274A4417D4FE2A0EAB0

The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include RYANODEX®, BENDEKA®, BELRAPZO®, and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210511006203/en/

Contacts

Investor Relations for Eagle Pharmaceuticals, Inc.:
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com